Jupiter Life Line Hospitals Limited (NSE:JLHL)
India · Delayed Price · Currency is INR 285.65
-0.85 (-0.30%)
Nov 12, 2026, 3:30 PM IST
NSE:JLHL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 16,207 | 14,998 | 13,024 | 10,734 | 8,925 | 7,331 |
Other Revenue | - | - | - | - | 3.56 | 40.21 |
| 16,207 | 14,998 | 13,024 | 10,734 | 8,929 | 7,371 | |
Revenue Growth | 17.85% | 15.15% | 21.33% | 20.22% | 21.13% | 50.36% |
Cost of Revenue | 6,299 | 5,769 | 5,084 | 4,022 | 3,317 | 2,922 |
Gross Profit | 9,908 | 9,228 | 7,940 | 6,712 | 5,612 | 4,450 |
Selling, General & Admin | 4,030 | 3,763 | 3,143 | 2,721 | 2,214 | 45.76 |
Other Operating Expenses | 2,267 | 2,009 | 1,754 | 1,560 | 1,377 | 2,830 |
Operating Expenses | 7,307 | 6,659 | 5,468 | 4,705 | 3,976 | 3,237 |
Operating Income | 2,602 | 2,569 | 2,472 | 2,007 | 1,636 | 1,213 |
Interest Expense | -378.92 | -273.06 | -34.19 | -226.61 | -387.43 | -366.55 |
Interest & Investment Income | 30.58 | 30.58 | 12.81 | 194.02 | 68.14 | - |
Earnings From Equity Investments | - | - | -0.08 | - | 20.72 | - |
Other Non Operating Income (Expenses) | -78.24 | -48.64 | -64.75 | -20.2 | -29.82 | -72.82 |
EBT Excluding Unusual Items | 2,175 | 2,278 | 2,385 | 1,954 | 1,308 | 773.16 |
Gain (Loss) on Sale of Investments | 376.75 | 376.75 | 250.11 | - | - | - |
Gain (Loss) on Sale of Assets | -1.82 | -1.82 | -28.75 | 0.03 | 1.61 | - |
Other Unusual Items | -48.87 | -48.87 | - | - | -22.04 | -1.98 |
Pretax Income | 2,501 | 2,604 | 2,607 | 1,954 | 1,287 | 771.18 |
Income Tax Expense | 634.67 | 662.49 | 669.22 | 188.03 | 558.03 | 259.9 |
Earnings From Continuing Operations | 1,866 | 1,942 | 1,938 | 1,766 | 729.05 | 511.28 |
Minority Interest in Earnings | -2.11 | -1.81 | -5.54 | - | - | - |
Net Income | 1,864 | 1,940 | 1,932 | 1,766 | 729.05 | 511.28 |
Net Income to Common | 1,864 | 1,940 | 1,932 | 1,766 | 729.05 | 511.28 |
Net Income Growth | -6.23% | 0.42% | 9.39% | 142.25% | 42.59% | 2184.40% |
Shares Outstanding (Basic) | 328 | 328 | 328 | 308 | 262 | 254 |
Shares Outstanding (Diluted) | 328 | 328 | 328 | 308 | 283 | 265 |
Shares Change | -0.02% | - | 6.49% | 8.94% | 6.67% | 4.16% |
EPS (Basic) | 5.69 | 5.92 | 5.89 | 5.74 | 2.78 | 2.01 |
EPS (Diluted) | 5.69 | 5.92 | 5.89 | 5.74 | 2.59 | 1.93 |
EPS Growth | -6.21% | 0.42% | 2.73% | 121.50% | 34.20% | 2093.21% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -3,505 | -2,341 | -608.48 | 292.26 | 399.24 | 452.4 |
Free Cash Flow Per Share | -10.69 | -7.14 | -1.86 | 0.95 | 1.41 | 1.71 |
Dividend Per Share | - | 0.200 | 0.200 | 0.200 | - | - |
Dividend Growth | - | 0% | 0% | - | - | - |
Gross Margin | 61.14% | 61.53% | 60.97% | 62.53% | 62.86% | 60.36% |
Operating Margin | 16.05% | 17.13% | 18.98% | 18.70% | 18.32% | 16.45% |
Profit Margin | 11.50% | 12.94% | 14.83% | 16.45% | 8.16% | 6.94% |
Free Cash Flow Margin | -21.63% | -15.61% | -4.67% | 2.72% | 4.47% | 6.14% |
EBITDA | 3,421 | 3,266 | 2,998 | 2,428 | 2,019 | 1,572 |
EBITDA Margin | 21.11% | 21.78% | 23.02% | 22.62% | 22.61% | 21.33% |
D&A For EBITDA | 819.04 | 696.67 | 526.14 | 420.79 | 383.01 | 359.48 |
EBIT | 2,602 | 2,569 | 2,472 | 2,007 | 1,636 | 1,213 |
EBIT Margin | 16.05% | 17.13% | 18.98% | 18.70% | 18.32% | 16.45% |
Effective Tax Rate | 25.38% | 25.44% | 25.67% | 9.62% | 43.36% | 33.70% |
Revenue as Reported | 16,601 | 15,422 | 13,307 | 10,955 | 9,030 | 7,371 |
Advertising Expenses | - | 86.76 | 46.4 | 7.53 | 35.32 | 45.76 |